Literature DB >> 627143

Gentamicin binding to serum and plasma proteins.

D R Myers, J DeFehr, W M Bennet, G A Porter, G D Olsen.   

Abstract

Gentamicin binding to serum proteins was studied by equilibrium dialysis at 37 degrees C and pH 7.4 in the presence of both physiologic and adjusted concentrations of ionized calcium and magnesium. The percentage of bound drug was inversely related to the concentration of these two divalent cations, raning from 27% bound with no calcium and magnesium present to 17% bound in the presence of four times physiologic concentrations. No significant difference in the extent of drug-protein binding was noted in a comparison of sera from healthy and uremic subjects. Heparin also was found to affect gentamicin binding. Increasing heparin concentration in serum increased apparent gentamicin-protein binding to 34% in the presence of physiologic amounts of calcium and magnesium. Buffered heparin solutions without plasma proteins bound up to 65% of total drug concentration. Gentamicin-protein binding may have implications regarding pharmacokinetics and renal cortical uptake.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627143     DOI: 10.1002/cpt1978233356

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Plasma or serum in therapeutic drug monitoring and clinical toxicology.

Authors:  D R Uges
Journal:  Pharm Weekbl Sci       Date:  1988-10-14

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Interaction of gentamicin with phosphatidylserine/phosphatidylcholine mixtures in adsorption monolayers and thin liquid films: morphology and thermodynamic properties.

Authors:  Georgi D Georgiev; Georgi As Georgiev; Z Lalchev
Journal:  Eur Biophys J       Date:  2010-03-04       Impact factor: 1.733

4.  Effect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamicin exposure.

Authors:  Campbell P Cross; Selena Liao; Zachary D Urdang; Priya Srikanth; Angela C Garinis; Peter S Steyger
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-09-09       Impact factor: 1.675

5.  Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Authors:  Maritza Barcia-Macay; Cristina Seral; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Differential effects of anesthetic regimens on gentamicin pharmacokinetics in the rat: a comparison with chronically catheterized conscious animals.

Authors:  M Gumbleton; P J Nicholls; G Taylor
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

7.  Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading.

Authors:  W M Bennett; W C Elliott; D C Houghton; D N Gilbert; J DeFehr; D A McCarron
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade.

Authors:  Won Ji Rhee; Seung Yoon Lee; Ji Hyeon Lee; So Ron Choi; Seung-Cheol Lee; Jong Hwan Lee; Soo-Il Lee
Journal:  Korean J Anesthesiol       Date:  2015-01-28

9.  Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?

Authors:  Soo-Il Lee; Ji Hyeon Lee; Sang Yoong Park; Jae-Won Park
Journal:  Korean J Anesthesiol       Date:  2013-04-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.